Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs COMP✓SelectedUSD · COMPGSK vs COMP performance historyLatest closeAs of-1.23%11/11
Stock and ETF performance explorer

GSK vs COMP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+77.5%
COMP return
-51.7%
Excess return
+129.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCOMPExcessAlpha
1D-1.2%+2.7%-3.9%-1.3%
7D-1.1%+2.2%-3.3%-1.2%
30D+7.8%+16.3%-8.5%+7.4%
3M+0.3%-19.1%+19.5%+0.7%
6M+3.4%+17.1%-13.7%+2.9%
YTD+5.9%-2.9%+8.8%+5.5%
1Y+8.2%+8.8%-0.6%+7.5%
3Y+65.3%+423.5%-358.2%+57.4%
5Y+43.3%-10.5%+53.8%+41.4%
All+77.5%-51.7%+129.2%+79.4%

Cumulative growth

Daily Returns

Daily percentage return beside COMP.

Daily Out/Under-Performance

Portfolio return minus COMP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × COMP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded COMP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling